Cvi Holdings, LLC Adamis Pharmaceuticals Corp Transaction History

Cvi Holdings, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.33 - $0.66 $1.12 Million - $2.24 Million	-3,397,916 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.33 - $0.89 $1.12 Million - $3.02 Million	3,397,916 New	3,397,916 $1.21 Million
Q4 2019 Feb 14, 2020	SELL	$0.51 - $1.26 $450,538 - $1.11 Million	-883,408 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.7 - $1.46 $618,385 - $1.29 Million	883,408 New	883,408 $622,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.